Syncona
company limited by shares
Syncona is a large British closed-ended investment trust dedicated to life science investments. Co-founded as Syncona Partners in 2012 by former CEO Martin Murphy and the Wellcome Trust, before merging with the Battle Against Cancer Investment Trust ('BACIT') in December 2016 and listing publicly, the company is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Its Chair is Melanie Gee.
Source: Wikipedia · CC BY-SA 4.0
last observed
Activity Score
0
confidence 80 % · metrics-v1
Hiring Momentum 30d
—
not enough monitored evidence
Product Velocity
0
confidence 70 % · metrics-v1
AI Adoption
0
confidence 60 % · metrics-v1
Corporate Change Index
0
confidence 76 % · cci-v1
9 active sensors·10 observations·0 historical changes·0 structured events·historical coverage 100 %·observed since 2026-09-14
Compare Syncona with peers on activity, hiring, product velocity, AI adoption, locations and events.
Compare companies
